CG Oncology (CGON) Assets (2023 - 2026)
CG Oncology's (CGON) quarterly Assets came in at $1.1 billion in Q1 2026, up 55.9% YoY from $728.2 million in Q1 2025, and up 43.42% on a QoQ basis from $791.6 million in Q4 2025.
CG Oncology (CGON) Assets (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Assets data on file, last reported at $1.1 billion in Q1 2026.
- Quarterly Assets rose 55.9% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 55.9% YoY) and the FY2025 annual result came in at $791.6 million, up 4.87% from the prior year.
- Assets advanced to $1.1 billion in Q1 2026, from $791.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $1.1 billion in Q1 2026 to a low of $199.3 million in Q4 2023.
- A 4-year average of $673.6 million and a median of $714.8 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets soared 278.72% — and 2025, when it gained 4.87%.
- Tracing CGON's Assets over 4 years: stood at $199.3 million in 2023, then soared by 278.72% to $754.8 million in 2024, then grew by 4.87% to $791.6 million in 2025, then jumped by 43.42% to $1.1 billion in 2026.
- The last three Assets figures came in at $1.1 billion (Q1 2026), $791.6 million (Q4 2025), and $729.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Bn |
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 791.59 Mn |
| Sep 30, 2025 | 729.91 Mn |
| Jun 30, 2025 | 701.45 Mn |
| Mar 31, 2025 | 728.18 Mn |
| Dec 31, 2024 | 754.80 Mn |
| Sep 30, 2024 | 552.47 Mn |
| Jun 30, 2024 | 564.33 Mn |
| Mar 31, 2024 | 579.11 Mn |
| Dec 31, 2023 | 199.30 Mn |